Oncopharmpod
Lenvatinib vs. Sorafenib (HCC)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:52
- Mas informaciones
Informações:
Sinopsis
Reviewing the REFLECT (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30207-1/fulltext) study and its take-home points on selecting an agent for advanced HCC.
